Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions
Pouyan Ghaffari, Saeed Shoaie, Lars K. Nielsen
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Machine learning and artificial intelligence in neuroscience: A primer for researchers
Fakhirah Badrulhisham, Esther Pogatzki‐Zahn, Daniel Segelcke, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 470-479
Open Access | Times Cited: 37
Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review
Vasile Valeriu Lupu, Cristina Mihaela Ghiciuc, Gabriela Ștefănescu, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 21, pp. 3241-3256
Open Access | Times Cited: 29
NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons
Andrew J. King, Lin Chang, Qian Li, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 5, pp. G543-G554
Open Access | Times Cited: 10
Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Parnian Jamshidi, Yeganeh Farsi, Zahra Nariman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14562-14562
Open Access | Times Cited: 16
Predicting Personalized Responses to Dietary Fiber Interventions: Opportunities for Modulation of the Gut Microbiome to Improve Health
Car Reen Kok, Devin J. Rose, Robert W. Hutkins
Annual Review of Food Science and Technology (2022) Vol. 14, Iss. 1, pp. 157-182
Open Access | Times Cited: 24
Is the Mediterranean Low Fodmap Diet Effective in Managing Irritable Bowel Syndrome Symptoms and Gut Microbiota? An Innovative Research Protocol
Arezina Kasti, Konstantinos Katsas, Konstantinos Petsis, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1592-1592
Open Access | Times Cited: 5
SÍNDROME DO INTESTINO IRRITÁVEL NO CONTEXTO DE ESTRESSE CRÔNICO VIVENCIADO PELOS ESTUDANTES DE MEDICINA
Jean Carlos Fernando Besson, Isadora Carolina Rissi Colombo, Enrique Ayres de Oliveira
Revista Contemporânea (2025) Vol. 5, Iss. 3, pp. e7748-e7748
Closed Access
The reality of modeling irritable bowel syndrome: progress and challenges
Maryam Sadat Fakhri‐Bafghi, Niloofar Khoshnam Rad, Ghazal Roostaei, et al.
Expert Opinion on Drug Discovery (2025) Vol. 20, Iss. 4, pp. 433-445
Closed Access
Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review
Mhd Bashir Almonajjed, Mahdi Wardeh, Abdallah Atlagh, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 109-109
Open Access
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Vicky Yao, Nairui Fan, Shuxia Ma, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis
Yuanfang Chen, Baotao Lian, Peize Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
Cholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?
Doina Georgescu, Daniel-Florin Lighezan, Ioana Ioniță, et al.
Diagnostics (2024) Vol. 14, Iss. 12, pp. 1234-1234
Open Access | Times Cited: 3
Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment
Junhui Li, Tarini Shankar Ghosh, Elke K. Arendt, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis
Shao‐Wei Lo, Tsung-Hsuan Hung, Yen-Tsen Lin, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Personalized Diets based on the Gut Microbiome as a Target for Health Maintenance: from Current Evidence to Future Possibilities
Eun‐Ji Song, Ji‐Hee Shin
Journal of Microbiology and Biotechnology (2022) Vol. 32, Iss. 12, pp. 1497-1505
Open Access | Times Cited: 15
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention
Thomas Lavoie, Haley J. Appaneal, Kerry L. LaPlante
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_6, pp. S447-S454
Open Access | Times Cited: 7
Alteración de la microbiota intestinal y su relación con enfermedades gastrointestinales y hepatobiliares
Mervin W. Villalobos-Orozco
Hepatología (2023) Vol. 4, Iss. 1, pp. 75-89
Open Access | Times Cited: 4
Functional Gastrointestinal Disorders
Molly Duffy, Victoria L. Boggiano, Ravindra Ganesh, et al.
Primary Care Clinics in Office Practice (2023) Vol. 50, Iss. 3, pp. 429-446
Closed Access | Times Cited: 4
Unraveling the Interplay: Exploring the Links Between Gut Microbiota, Obesity, and Psychological Outcomes
Divya Saravanan, Suhana Khatoon B, Jefry Winner G
Cureus (2023)
Open Access | Times Cited: 4
Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial
Hyeji Kwon, Eoun Ho Nam, Hayoung Kim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Comprehensive Investigation of the Influence of High-Altitude Hypoxia on Clopidogrel Metabolism and Gut Microbiota
Jilei Zhang, Yuemei Sun, Jiaxin He, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 10, pp. 723-733
Closed Access | Times Cited: 3
An 8-Week Course of Bifidobacterium longum 35624® Is Associated with a Reduction in the Symptoms of Irritable Bowel Syndrome
Marion Lenoir, Jörg Wienke, Frédérique Fardao-Beyler, et al.
Probiotics and Antimicrobial Proteins (2023)
Open Access | Times Cited: 3
A Systematic Review on the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in Gastrointestinal Motility Disorders: More Control, Less Risk
Maitri V Acharekar, Sara Elena Guerrero Saldivia, Sumedha Unnikrishnan, et al.
Cureus (2022)
Open Access | Times Cited: 5
Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake
Line Pourtau, Fabien Wauquier, Line Boutin-Wittrant, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 336-336
Open Access
Sex Differences in Colonic Mucosal Microbiome of Irritable Bowel Syndrome Patients Compared to Healthy Controls
Swapna Mahurkar‐Joshi, Simer Shera, Jennifer S. Labus, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top